Feedback / Questions
pemvidutide (ALT-801) - Altimmune
https://www.globenewswire.com/news-release/2026/08/03/3337439/0/en/Altimmune-Initiates-PERFORMA-Phase-3-Trial-of-Pemvidutide-in-Patients-with-MASH.html
Aug 3, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next